With a robust background in healthcare investments, the fund manager has successfully executed over 30 deals across various stages, from seed to growth equity. Their strategic approach emphasizes operator-first principles, ensuring a deep understanding of the medical technology landscape. Active primarily in North America and Europe, they have achieved notable exits that underscore their ability to identify and nurture high-potential companies. The focus on data-driven decision-making has led to a diverse portfolio, reflecting a commitment to innovation in key sectors such as digital health and medical devices.